Founder And CEO
Co-Founding Partner and COO
Chief Financial Officer
Chief People Officer
Chief Growth Officer
Partner, Launch Excellence Practice Lead
Partner
Partner, Patient Services Practice Lead
Principal, Market Access
Principal, Medical Communications
Principal, Value and Access Communications
Principal, Evidence and Value
Partner
Principal, Science and Strategy
General Manager, Sr. Partner
Principal
Partner
Principal, Market Access
Principal, Market Access
Principal
Principal, Science and Strategy
Chief Growth Officer
Vice President, Commercialization
Senior Vice President, Commercialization
Vice President, Business Development
Executive Vice President, Business Development
Senior Vice President, Commercialization
Santosh Naik is a Partner at Herspiegel. He has leveraged his passion for solving critical business issues to advise clients ranging from start-ups to large pharmaceutical and biotechnology firms. He is driven by helping clients develop and execute commercial strategies and solutions that are both realistic and impactful.
While at Herspiegel, Santosh has overseen projects across multiple therapeutic areas including oncology, rare disease, psychiatry, neurology, migraine, women’s health, and pain management. His expertise includes advising clients on brand planning, go-to-market strategy development, and launch readiness and execution. He has advised clients on over 20 unique assets as they prepare for launch.
Prior to joining Herspiegel, Santosh held positions at Forest Labs, later acquired by Actavis, and Becton Dickinson, a leading medical device company. He holds an MBA in pharmaceutical marketing from Rutgers University and a BS in biomedical engineering from Georgia Tech.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
Navigate your start-up's first pharma launch with confidence! Discover 4 key success factors in our guide. Start excelling today.
Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
A mid-sized global pharmaceutical organization entered a co-commercialization agreement with a top-10 pharmaceutical organization to launch its first product in oncology.
Maximize portfolio impact! Learn key co-positioning strategies for products in our latest whitepaper. Boost performance now.
Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.
Unlock personalized drug launch success with Herspiegel's archetype strategies. Dive into tailored planning for impactful market entry.
Navigate your start-up's first pharma launch with confidence! Discover 4 key success factors in our guide. Start excelling today.
Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.
Maximize portfolio impact! Learn key co-positioning strategies for products in our latest whitepaper. Boost performance now.
Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.
Unlock personalized drug launch success with Herspiegel's archetype strategies. Dive into tailored planning for impactful market entry.
Careers page, Principal profile
"*" indicates required fields
Careers page Analyst profile
Careers page Manager profile